Reposted
RRecordati@recordati
Recordati Industries S.p.A. (Milano, Italia). 2024 revenue ~€2.2B. Rare diseases: Carbaglu, Isturisa, Recorlev. General medicine: Lomir, Zanipress. Founded 1926. Family-controlled.
8:29:11 PM · Jul 9, 2026
Recordati Industries S.p.A. (Milano, Italia). 2024 revenue ~€2.2B. Rare diseases: Carbaglu, Isturisa, Recorlev. General medicine: Lomir, Zanipress. Founded 1926. Family-controlled.
Wet bead milling to 200 nm improved the dissolution rate dramatically.
Our liquid-liquid extraction achieved 99.5% recovery with minimal emulsion formation.
The viral inactivation step at pH 3.5 for 60 min showed >5 log10 clearance.